Abstract
Eighty-seven newborns with persistent atelectasis who did not respond to traditional treatment were studied retrospectively. Patient groups: Group 1 (Control): didn't receive nebulizer drugs; Group 2: received 7%HS;Group3: received rhDNase; andGroup 4: received both 7%HS and rhDNase. Subjects' preand post-treatment chest X-ray scores, PCO2, respiratory rate, FiO2, PIP, atelectasis healing rate and median duration of nebulizer treatment and costs were compared.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.